Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension

PLoS ONE - United States
doi 10.1371/journal.pone.0080674
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Phosphodiesterase Type 5 Inhibitors in the Treatment of Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

RESPITE: Switching to Riociguat in Pulmonary Arterial Hypertension Patients With Inadequate Response to Phosphodiesterase-5 Inhibitors

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Editorial: Problems in Renovascular Hypertension.

BMJ
1973English

Renovascular Hypertension: Case Report

Srce i krvni sudovi
2012English

Inhibition of Type-5 Phosphodiesterase: Promising Therapy for Pulmonary Hypertension

Internal Medicine
Internal MedicineMedicine
2004English

Management of Renovascular Hypertension in the Elderly Population

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
1990English

Operative Management of Renovascular Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
1984English

Cardiovascular Manifestations of Renovascular Hypertension in Diabetic Mice

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2016English

Fibromuscular Dysplasia: Another Paradigm Shift in Renovascular Hypertension?

Internal Medicine
Internal MedicineMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy